SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (43213)10/24/2009 12:28:18 PM
From: Hope Praytochange  Read Replies (1) of 110194
 
The U.S. government has invested more than $2 billion to develop newer, faster methods of vaccine production, but these aren't yet ready for response to a pandemic. The pandemic is "testing the global influenza manufacturing system," said Bruce Gellin, director of the National Vaccine Program Office.

The delays raise questions as to how well the vaccine supply will be able to stem the current wave of infection.

The H1N1 flu has infected millions of people in the U.S., the CDC said. While it makes most people only mildly ill, it also has caused severe disease and deaths, including in children and otherwise-healthy young people.

"Forty-six states having widespread transmission is the peak of flu season. To be basically in the peak of flu season in October is extremely unusual," Dr. Frieden said. "We expect this influenza will occur in waves. We can't predict how high, how far, or how long the wave will go or when the next will come."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext